Press "Enter" to skip to content

Sun Pharma gets 4 observations from USFDA for its Halol facility

The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAl) of company’s Halol facility from June 3 to June 11, 2019, Sun Pharma said in a filing to the BSE.

Original source: https://health.economictimes.indiatimes.com/news/pharma/sun-pharma-gets-4-observations-from-usfda-for-its-halol-facility/69899475?utm_source=RSS&utm_medium=ETRSS

Also Read:   Pentagon looking to provide up to 100,000 body bags for civilians in virus outbreak